What is Augmedics?
Augmedics is an augmented reality surgical image guidance pioneer that aims to improve healthcare by augmenting surgery with cutting-edge technologies that solve unmet clinical needs and instill technological confidence in the surgical workflow. By integrating advanced visualization tools directly into the operating room, the company provides surgeons with real-time, high-precision data, effectively bridging the gap between digital imaging and physical intervention. This market position places Augmedics at the intersection of medical device innovation and digital health, where it continues to redefine standards for surgical accuracy and patient outcomes.
How much funding has Augmedics raised?
Augmedics has raised a total of $141.8M across 4 funding rounds:
Series A
$8.3M
Series B
$15M
Unspecified
$36M
Series D
$82.5M
Series A (2017): $8.3M with participation from AO Invest and Terra Venture Partners
Series B (2020): $15M, investors not publicly disclosed
Unspecified (2021): $36M supported by Almeda Ventures, Revival Healthcare Capital, H.I.G. Capital, XR Investment, and Hospital Corporation of America
Series D (2023): $82.5M featuring Revival Healthcare Capital, H.I.G. Capital, Cpmg, and Almeda Ventures
Key Investors in Augmedics
H.I.G. Capital
H.I.G. Capital is a global alternative investment firm headquartered in Miami, Florida, founded in 1993. The firm provides debt and equity capital to small and middle-market companies through funds focused on private equity, growth equity, real estate, direct lending, credit, infrastructure, and healthcare.
Revival Healthcare Capital
Founded in 2018 and headquartered in Austin, Texas, Revival Healthcare Capital is a company that provides its partners with tools and advice to optimize potential capital.
Almeda Ventures
Almeda Ventures is the first HealthTech focused public R&D partnership that invests globally in medical devices, digital health, and bio-convergence, aiming to drive the success of innovative healthcare solutions.
What's next for Augmedics?
With the infusion of capital from its latest funding round, Augmedics is well-positioned to accelerate its product development roadmap and broaden its commercial reach. The strategic focus will likely center on deepening the integration of its AR platforms within hospital systems, enhancing the software capabilities of its existing hardware, and navigating the regulatory pathways for international market entry. As the company transitions from a high-growth startup to an established enterprise player, the emphasis will remain on maintaining its competitive edge through continuous innovation and strategic partnerships with major healthcare providers and medical technology investors.
See full Augmedics company page
